2018
DOI: 10.1002/ccd.27971
|View full text |Cite
|
Sign up to set email alerts
|

Spontaneous coronary artery dissection treated with magnesium‐made bioresorbable scaffold: 1‐Year angiographic and optical coherence tomography follow‐up

Abstract: A young woman admitted with a diagnosis of NSTE‐ACS underwent coronary angiography which showed LAD spontaneous coronary artery dissection treated with magnesium‐made bioresorbable scaffold. We report 1‐year angiographic and OCT findings.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

2019
2019
2020
2020

Publication Types

Select...
6

Relationship

3
3

Authors

Journals

citations
Cited by 8 publications
(4 citation statements)
references
References 15 publications
0
4
0
Order By: Relevance
“…Moreover, QFR assessment after PCI of culprit vessel in ACS may be influenced by subtended microvascular dysfunction secondary to myocardium infarction 25 . Overall, our results should be considered as hypothesis generating and not conclusive but contribute to extend current data on magnesium‐based resorbable sirolimus‐eluting scaffold performance in complex settings 26‐28 …”
Section: Limitationsmentioning
confidence: 82%
See 1 more Smart Citation
“…Moreover, QFR assessment after PCI of culprit vessel in ACS may be influenced by subtended microvascular dysfunction secondary to myocardium infarction 25 . Overall, our results should be considered as hypothesis generating and not conclusive but contribute to extend current data on magnesium‐based resorbable sirolimus‐eluting scaffold performance in complex settings 26‐28 …”
Section: Limitationsmentioning
confidence: 82%
“…25 Overall, our results should be considered as hypothesis generating and not conclusive but contribute to extend current data on magnesium-based resorbable sirolimus-eluting scaffold performance in complex settings. [26][27][28] 6 | CONCLUSION…”
Section: Discussionmentioning
confidence: 99%
“…Ongoing clinical trials (MAGSTEMI) are, however, evaluating the performance of Magmaris in STEMI patients in comparison with Orsiro. Regarding other acute coronary syndrome settings, a recent case report suggests the possibility to take advantage of resorbable magnesium scaffold to treat spontaneous coronary dissection, in order to obtain long-term restoration of coronary vasomotion [58,59]. Finally, patients who cannot comply with current ESC/EAPCI DAPT recommendations for stable lesions must not be treated with Magmaris scaffold [14].…”
Section: When Should I Place a Magmaris Scaffold?mentioning
confidence: 99%
“…The last but not the least, intracoronary imaging may be used during follow-up in case of implant of a bio-resorbable scaffold in order to assess the complete resorption of the device 32 , a promising technique that may help to take care of the SCAD without leaving permanent stents in young patients.…”
Section: Follow-upmentioning
confidence: 99%